Cullinan Associates’s Cavium, Inc. CAVM Stock Holding History

Cullinan Associates’s Portfolio CAVM Stock Details CAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-10,528	Closed	-$406K	–	206
2016 Q2	$406K	Hold	10,528	–	–	0.03%	168
2016 Q1	$644K	Hold	10,528	–	–	0.06%	149
2015 Q4	$692K	Hold	10,528	–	–	0.06%	148
2015 Q3	$646K	Hold	10,528	–	–	0.06%	161
2015 Q2	$724K	Hold	10,528	–	–	0.06%	163
2015 Q1	$746K	Buy	+10,528	New	+$683K	0.06%	162

Other funds holding CAVM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

abrdn Investment Management Edinburgh, United Kingdom $29.6B AUM 25.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cullinan Associates's CAVM Position: Q3 2016 in Review

Cullinan Associates sold out of Cavium, Inc. (CAVM) in Q3 2016, closing a stake of 10,528 shares — an estimated $406K sold.

Cullinan Associates first reported a position in CAVM in Q1 2015 and held it in 6 quarters. The position peaked at $746K in Q1 2015. 230 funds tracked by Wall St. Rank hold CAVM as of Q3 2016.

Cullinan Associates reported no remaining Cavium, Inc. position as of Q3 2016 after selling out during the quarter.
Cullinan Associates sold 10,528 Cavium, Inc. shares in Q3 2016, an estimated $406K.
Cullinan Associates first reported a position in Cavium, Inc. in Q1 2015 and held it in 6 quarters.
Cullinan Associates's Cavium, Inc. position peaked at $746K in Q1 2015.
230 funds tracked by Wall St. Rank held Cavium, Inc. as of Q3 2016.

Based on Cullinan Associates's 13F filing for Q3 2016, filed 3 Oct 2016.